Through IHC analysis, Girgis reported that overexpressed LDHA was associated with poor prognosis (including disease-free survival and OS) in 385 ccRCC patients, which validated its OS in an independent 170 ccRCC patients from TCGA databases (Girgis et al., 2014). This evidence concerns the gene LDHA and nonpapillary renal cell carcinoma.